Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00131742
Recruitment Status : Completed
First Posted : August 19, 2005
Last Update Posted : May 12, 2015
Novartis Pharmaceuticals
Information provided by:

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2007
  Study Completion Date : January 2007